Video

Dr Lonny Reisman Outlines His Expectations for the Future of Managed Care

The digitization of health will help to identify patients when they're most vulnerable and present new opportunities to change the trajectory of their disease before they suffer avoidable consequences associated with chronic disease, said Lonny Reisman, MD.

The digitization of health will help to identify patients when they're most vulnerable and present new opportunities to change the trajectory of their disease before they suffer avoidable consequences associated with chronic disease, said Lonny Reisman, MD, chief executive officer of HealthReveal.

Transcript (slightly modified for readability)

How will managed care change over the next 20 years?

I think over the next 20 years managed care will begin to manifest some of the issues and benefits associated with value-based contracting and decision making regarding best providers, best delivery system, best care team apparatus, and importantly will exploit the marvelous capability we have now through the digitization of health to really identify patients at a moment in time when they're arguably most vulnerable, but also where there's an opportunity to impact, intervene, and change the trajectory of their disease so they don't suffer some of the avoidable consequences associated with chronic disease.

And we will have introduced new mechanisms for cost containment, which will be critically important as we think about the ecnomic impact of healthcare costs on our ability to create the sort of society we're all committed.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Martin Engelke
David Awad, PharmD, BCOP
Dr Adela Perolla
Dr Adela Perolla | Image Credit: - stock.adobe.com
Dr Ola Landgren
Dr Ola Landgren
Andrew Kuykendall, MD, Moffitt Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo